Cantor Fitzgerald Brokers Reduce Earnings Estimates for ACAD
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Equities research analysts at Cantor Fitzgerald cut their FY2025 earnings estimates for shares of ACADIA Pharmaceuticals in a research report issued to clients and investors on Thursday, February 27th. Cantor Fitzgerald analyst C. Duncan now anticipates that the biopharmaceutical company will post earnings per share of $0.15 […]
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Equities research analysts at Cantor Fitzgerald cut their FY2025 earnings estimates for shares of ACADIA Pharmaceuticals in a research report issued to clients and investors on Thursday, February 27th. Cantor Fitzgerald analyst C. Duncan now anticipates that the biopharmaceutical company will post earnings per share of $0.15 […]
